Skip to main content
Journal ArticleOPEN ACCESS

Recurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report

Journal of the Royal Society of Medicine (2020) 113(11) 454-456
DOI: 10.1177/0141076820961087
1Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Tamoxifen exposure is a recognised risk for primary endometrial cancer. This case serves as a reminder to meticulously check the past medical history and inform patients of the risk-benefit of treatment as part of a shared-decision making process.

Author supplied keywords

Cite

CITATION STYLE

APA

Woolas, J., Davis, M., & Rahimi, S. (2020). Recurrence of endometrial cancer in a hysterectomised patient treated with tamoxifen for breast cancer: a case report. Journal of the Royal Society of Medicine, 113(11), 454–456. https://doi.org/10.1177/0141076820961087

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free